Integragen Transforming molecular information
Go to content
  • Français
Contact IntegraGen on Twitter IntegraGen on LinkedIn IntegraGen - RSS feed
  • Areas of Interest
    • Clinical Research
    • Basic and Human Genetic Research
    • Agrigenomics
    • Microbial Genomics
  • Service Solutions
    • DNA Sequencing
    • Transcriptomics
    • Epigenomics
    • SNP Genotyping
  • Bioinformatics
    • MERCURY
    • SIRIUS
    • GALILEO
    • GeCo – Advanced Genomic Consulting Service
  • About Us
    • Company Overview
    • Management Team
    • Careers
    • Board of Directors
    • ISO 13485:2016 Certification
  • News and Events
    • Press releases
    • Latest News
    • Upcoming Events
  • Investors
    • OncoDNA Friendly Takeover Bid
    • Corporate Presentations
    • Number of shares and voting rights
    • Liquidity contract reactivation
    • Press releases
    • Share Information
    • Calendar for Publications
    • Financial Documents
      • Financial Reports
      • Liquidity Contract
    • Shareholder Meetings
    • Investor Contacts
    • Receive updates about IntegraGen
  • Contact Us
    • Office locations
      • Need Directions?
    • Request a demo
    • Contact us
    • Receive updates about IntegraGen
Home » News and Events » Press releasesPage 6

Press releases

24 March 2015

Institut Pasteur and IntegraGen announce alliance

The Institut Pasteur and IntegraGen today announced the signing of a partnership agreement making IntegraGen the the operator of sequencing activities for the National Reference Centres (NRC) and microbiological collections of the Institut Pasteur.

Link to press release

05 February 2015

IntegraGen Announces Distribution Agreement for Autism Test

autism-integragen

IntegraGen has announced a distribution agreement for it’s autism risk assessment test. Genoma SA, a subsidiary of the Espirite group, has obtained the rights to market and distribute the autism genetic predisposition test developed by IntegraGen outside the United States.

Link to IntegraGen press release    Link (…)  » 

13 January 2015

IntegraGen’s revenue increases 12% in 2014

integragen

IntegraGen announced today the company’s sales results for the year ending December 14, 2014 increased 12% in 2014 to € 6.04 million.

Link to press release

16 December 2014

Collaboration with PICCOLO study investigators for miR-31-3p

IntegraGen has announced a collaboration with the team of investigators from the PICCOLO study to further validate the role of biomarker hsa-miR-31-3p in metastatic colorectal cancer (mCRC).

Link to press release

15 December 2014

IntegraGen licenses liver cancer molecular signatures

IntegraGen has announced that it has entered into an agreement providing the company with the worldwide licensing rights for two hepatocellular carcinoma molecular signatures which have potential clinical utility for monitoring patients with liver cancer.

Click here to view press release.

Page 6/6 « 1 … 3 4 5 6

  • Press releases
  • Latest News
  • Upcoming Events
Subscribe to our mailing list
Subscribe »
Integragen
  • Areas of Interest
    • Clinical Research
    • Basic and Human Genetic Research
    • Agrigenomics
    • Microbial Genomics
  • Service Solutions
    • DNA Sequencing
    • Transcriptomics
    • Epigenomics
    • SNP Genotyping
  • Bioinformatics
    • MERCURY
    • SIRIUS
    • GALILEO
    • GeCo – Advanced Genomic Consulting Service
  • About Us
    • Company Overview
    • Management Team
    • Careers
    • Board of Directors
    • ISO 13485:2016 Certification
  • News and Events »
  • Investors »
  • Contact Us »
  • General Terms and Conditions of Services .
  • Home .
  • Request Quote .
  • Legal Policy .
  • Site map .
Copyright © 2021 IntegraGen. All rights reserved. »